FOURTH AMENDMENT TO AMENDED AND RESTATED NERVE TISSUE PROCESSING AGREEMENTNerve Tissue Processing Agreement • November 13th, 2014 • AxoGen, Inc. • Electromedical & electrotherapeutic apparatus
Contract Type FiledNovember 13th, 2014 Company IndustryTHIS FOURTH AMENDMENT (“Fourth Amendment”) to the Amended and Restated Nerve Tissue Processing Agreement dated February 27, 2008 as amended from time to time (the “Agreement”), is effective upon last signature hereto by and between LifeNet Health (“LIFENET Health”) and AxoGen Corporation (“AXOGEN”).